How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
J Clin Oncol. 2017 May 04;:JCO2016718072
Authors: Szturz P, Seiwert TY, Vermorken JB
PMID: 28471725 [PubMed - as supplied by publisher]
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pH1Jyw
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου